Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Vasan

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Clinical Breast Cancer|December 24, 2021
Genomic Characterization of De Novo Metastatic Breast CancerSamyukta Mullangi, Neil Vasan
Cell Chemical Biology|July 19, 2024
Therapeutic potential of inhibiting the PI3Kγ complex for leukemiaHanna Karvonen, Neil Vasan
Nature Reviews. Clinical Oncology|April 28, 2022
At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapyNeil Vasan, Lewis C Cantley
Cancer Research|September 15, 2025
A New VISTA in Intracellular Checkpoint Signaling in Triple-Negative Breast CancerJacqueline J Tao, Neil Vasan
Cancer Discovery|November 1, 2023
A New Wave of PI3Kα InhibitorsAlison L Kearney, Neil Vasan
Nature|November 15, 2019
A view on drug resistance in cancerNeil Vasan, José Baselga, David M Hyman
BMJ Case Reports|December 11, 2012
Metastatic leiomyosarcoma presenting as bilateral, multifocal breast massesNeil Vasan, Ozlen Saglam, Brigid K Killelea
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancerNeil Vasan, Julie L Boyer, Roy S Herbst
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Structure of a C-terminal fragment of its Vps53 subunit suggests similarity of Golgi-associated retrograde protein (GARP) complex to a family of tethering complexesNeil Vasan, Alex Hutagalung, Peter Novick, et al.
Nature Reviews. Drug Discovery|March 30, 2026
A renaissance in targeting the PI3K/AKT/mTOR pathwaySarah E Conduit, Neil Vasan, Jennifer R Brown, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical Breast Cancer|December 24, 2021
Genomic Characterization of De Novo Metastatic Breast CancerSamyukta Mullangi, Neil Vasan
Cell Chemical Biology|July 19, 2024
Therapeutic potential of inhibiting the PI3Kγ complex for leukemiaHanna Karvonen, Neil Vasan
Nature Reviews. Clinical Oncology|April 28, 2022
At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapyNeil Vasan, Lewis C Cantley
Cancer Research|September 15, 2025
A New VISTA in Intracellular Checkpoint Signaling in Triple-Negative Breast CancerJacqueline J Tao, Neil Vasan
Cancer Discovery|November 1, 2023
A New Wave of PI3Kα InhibitorsAlison L Kearney, Neil Vasan
Nature|November 15, 2019
A view on drug resistance in cancerNeil Vasan, José Baselga, David M Hyman
BMJ Case Reports|December 11, 2012
Metastatic leiomyosarcoma presenting as bilateral, multifocal breast massesNeil Vasan, Ozlen Saglam, Brigid K Killelea
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancerNeil Vasan, Julie L Boyer, Roy S Herbst
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Structure of a C-terminal fragment of its Vps53 subunit suggests similarity of Golgi-associated retrograde protein (GARP) complex to a family of tethering complexesNeil Vasan, Alex Hutagalung, Peter Novick, et al.
Nature Reviews. Drug Discovery|March 30, 2026
A renaissance in targeting the PI3K/AKT/mTOR pathwaySarah E Conduit, Neil Vasan, Jennifer R Brown, et al.
Pageof 4